Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HUMAN PAPILLOMA VIRUS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06610773
What this trial is testing

HUC-MSC for Treatment of High-risk HPV Infection

Who this might be right for
Human Papillomavirus VirusesMesenchymal Stem Cells
Shanghai East Hospital 60
Post-approval studies (Phase 4)Active Not RecruitingNCT05557370
What this trial is testing

Immunogenicity of HPV Vaccine in Transplant Recipients.

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Medical College of Wisconsin 30
Not applicableStudy completedNCT02280642
What this trial is testing

Alternate Dosing Schedules Study for HPV Vaccine (ADS)

Who this might be right for
Cervical CancerGenital Warts
Duke University 331
Not applicableStudy completedNCT05256862
What this trial is testing

Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania

Who this might be right for
Cervical Cancer Screening
University Hospital, Basel, Switzerland 2,974
Testing effectiveness (Phase 2)Study completedNCT01492582
What this trial is testing

Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

Who this might be right for
Cancer SurvivorPrevention of Human Papillomavirus Infection
University of Alabama at Birmingham 1,499
Not applicableStudy completedNCT04950101
What this trial is testing

Prevalence of Anal High-risk Human Papilloma Virus Infection and Abnormal Anal Cytology in Men Who Have Sex With Men Using Pre Exposure Prophylaxis

Who this might be right for
Human Papilloma Virus
Universitair Ziekenhuis Brussel 304
Not applicableUnknownNCT05531981
What this trial is testing

Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer

Who this might be right for
Uterine Cervical Neoplasms
Peking Union Medical College Hospital 350
Not applicableWithdrawnNCT03445416
What this trial is testing

Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men

Who this might be right for
MeningitisHPV - Anogenital Human Papilloma Virus InfectionHepatitis A
Ann & Robert H Lurie Children's Hospital of Chicago
Testing effectiveness (Phase 2)Ended earlyNCT02540928
What this trial is testing

AMG 319 in HPV Positive and Negative HNSCC

Who this might be right for
Human Papillomavirus (HPV)Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx
Cancer Research UK 35
Early research (Phase 1)WithdrawnNCT05472220
What this trial is testing

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

Who this might be right for
Solid Tumors, AdultPIK3CA Mutation-Related TumorsPIK3CA Mutation+5 more
Pamela Munster
Not applicableUnknownNCT03742869
What this trial is testing

HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma

Who this might be right for
Cervical AdenocarcinomaHuman PapillomavirusGenome-wide Association Study+5 more
Lei Li 40
Large-scale testing (Phase 3)Study completedNCT03431246
What this trial is testing

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Who this might be right for
Human Papillomavirus Vaccines
Laval University 32
Not applicableLooking for participantsNCT06254846
What this trial is testing

Evaluation of First-void Urine as an Alternative to Cervical Sampling for Human Papillomavirus (HPV) Testing in Cervical Cancer Screening (Single-center Study).

Who this might be right for
Uterine Cervical Cancer
Centre Hospitalier Universitaire de Saint Etienne 350
Large-scale testing (Phase 3)Study completedNCT00196924
What this trial is testing

Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18.

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 2,067
Not applicableStudy completedNCT03002324
What this trial is testing

Tailoring of Vaccine-Focused Messages: Disease Salience

Who this might be right for
Human Papillomavirus
Emory University 1,320
Large-scale testing (Phase 3)Study completedNCT00637195
What this trial is testing

Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 152
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Testing effectiveness (Phase 2)Ended earlyNCT03799445
What this trial is testing

Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma+8 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00586339
What this trial is testing

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT02529930
What this trial is testing

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Who this might be right for
High Grade Cervical Intraepithelial Neoplasia
Nykode Therapeutics ASA 34
Next Page
37